Update #8: American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic
Sep 08, 2020
Published in: ASRM Bulletin
Since the last update, the Task Force has observed the following:
- As of September 1, 2020, the U.S. unfortunately continues to lead the world in COVID-19 deaths and cases per capita. COVID-19 cases have exceeded six million in the U.S. with more than 185,000 deaths.
- In the U.S., the disease disproportionately affects Latino and African American individuals and it is now recognized that COVID-19 can significantly affect younger adults and children.
- While the U.S. has experienced an almost 40% decrease in the seven-day average for new cases since the beginning of August, there are still wide variances in the rates of new cases and deaths throughout the nation. For example, the number of new cases continues to decline in the Northeast but are on the upswing in parts of the Midwest and South.
- Widespread misinformation has led to sub-optimal implementation and acceptance of recognized strategies to prevent and minimize the transmission of the disease, which have led to some confusion among patients regarding current recommendations.
In the current revision, the Task Force continues to support the judicious delivery of fertility care with strict adherence to recommended measures for disease prevention, including implementation of travel restrictions and quarantines when appropriate.
Read the full document here.
The next update from the Task Force will be in four weeks (on or about October 5, 2020), unless conditions warrant earlier release.
The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at firstname.lastname@example.org.